Gabriel Plotkin Abb Vie Inc. Transaction History
Melvin Capital Management LP
- $0
- Q3 2023
A detailed history of Gabriel Plotkin (Melvin Capital Management LP) transactions in Abb Vie Inc. stock. As of the latest transaction made, Melvin Capital Management LP holds 442,700 shares of ABBV stock, worth $77.7 Million. This represents 0.37% of its overall portfolio holdings.
Number of Shares
442,700Holding current value
$77.7 Million% of portfolio
0.37%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ABBV
# of Institutions
3,853Shares Held
1.25BCall Options Held
16.8MPut Options Held
12.2M-
Vanguard Group Inc Valley Forge, PA172MShares$30.1 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$24 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$13.9 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.1MShares$9.15 Billion0.84% of portfolio
-
Morgan Stanley New York, NY38.7MShares$6.8 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $310B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...